A groundbreaking drug has nearly doubled survival rates for pancreatic cancer patients, offering new hope in the fight ...

A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Scientists at the University of Edinburgh, working alongside NHS Lothian, have unveiled a promising new technique that could ...

Agenus shifts to BOT+BAL in neoadjuvant MSS colon cancer; $85M raise extends runway to 2031. Click here to read this latest ...

A Faulkner County man is now living cancer-free after a frightening blood cancer diagnosis thanks to new treatment options at ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...

At the Hirslanden clinic overlooking Switzerland’s picturesque Lake Lucerne, prostate cancer patient Jörg Pegelow lies on a reclining chair as a doctor wearing two sets of gloves — one made with lead ...

Add Yahoo as a preferred source to see more of our stories on Google. We are celebrating that breakthrough at the precise moment Washington is taking apart the research base behind it. On May 29, the ...